Oligodendrocytic protein contribute to neuronal accumulation of alpha-synuclein in multiple system atrophy
Project/Area Number |
25830045
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Nerve anatomy/Neuropathology
|
Research Institution | Institute for Developmental Research, Aichi Human Service Center (2014) National Center for Geriatrics and Gerontology (2013) |
Principal Investigator |
SUZUKI Yasuyo 愛知県心身障害者コロニー発達障害研究所, 遺伝学部, 研究員 (60416188)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | α-synuclein / 神経変性疾患 / 多系統萎縮症 / 神経科学 / 多系統委縮症 / シスタチンC |
Outline of Final Research Achievements |
Multiple system atrophy (MSA) is a neurodegenerative disease in which oligodendrocytes and neurons in the central nervous system are affected. To clarify how oligodendrocytic α-synuclein inclusions cause neuronal degeneration, we generated a transgenic mouse for an MSA model in which human wild-type α-synuclein was overexpressed selectively in oligodendrocytes. We established primary culture cells derived from the brain of transgenic mice, and revealed that insoluble mouse α-synuclein was progressively accumulated in neurons, leading to neuronal dysfunction and degeneration. In this study, we identified cystatin C as a neurodegeneration-inducing factor released from oligodendrocytes. Cystatin C triggers insoluble α-synuclein accumulation in neurons of the mouse central nervous system.
|
Report
(3 results)
Research Products
(6 results)